The Food and Drug Administration has approved a blood test intended to detect colorectal cancer, expanding options for screening for the potentially deadly disease.

The FDA has approved a new blood test for colorectal cancer. Shield, made by Guardant Health, is the first approved blood test that is considered a primary screening option for the disease.

Cancer FDA approves new blood test to detect colon cancer Colonoscopies remain the gold standard, but this new test could increase screening. By Laura Baisas Published Jul 29, 2024 10:37 AM EDT ...

The FDA on Monday approved a blood test to screen for colorectal cancer among those aged 45 and older with an "average risk." ...

The Food and Drug Administration has approved a new blood test that could screen for colorectal cancer in some people.

The FDA on Monday approved a blood test to screen for colorectal cancer among those aged 45 and older with an "average risk." ...

A clinical trial is launching to test the effectiveness of new tests that aim to detect genetic signatures of cancer in the ...

A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of ...

The National Cancer Institute-funded study, which will include up to 24,000 people, will screen for a variety of cancers. More news is on dogs detecting Parkinson's; progress in the Influenza Vaccines ...

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.